Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Operating activities:
Net income (loss)	$ 49,224	$ 43,071
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	23,268	22,840
Amortization of deferred financing costs	486	671
Deferred income taxes	(1,597)	811
Bad debt expense	1,201	1,018
Stock-based compensation	6,441	4,531
Other non-cash items	(23)	(301)
Changes in operating items:
Trade receivables	(15,044)	(7,249)
Inventories	19,353	14,448
Prepaid and other	3,148	2,675
Accounts payable and accrued expenses	31,442	14,741
Other assets and liabilities	(557)	(251)
Net cash provided by operating activities	117,342	97,005
Investing activities:
Acquisitions, net of cash acquired	(20,500)
Capital expenditures, net of non-cash expenditures	(22,282)	(16,845)
Purchase of equity investments	(1,176)
Net cash used in investing activities	(43,958)	(16,845)
Financing activities:
Acquisition of treasury stock	(10,667)	(14,765)
Proceeds from exercise of employee stock options	285	929
Proceeds from bank borrowings	20,000	30,000
Repayment of notes payable and bank borrowings	(23,750)	(37,187)
Debt issuance cost	(60)
Net cash used in financing activities	(14,192)	(21,023)
Net change in cash and cash equivalents	59,192	59,137
Cash and cash equivalents:
Beginning of period	172,923	147,240
End of period	$ 232,115	$ 206,377